Up-regulation of SGPL1 along with reduced levels of SPHK1 and subsequent decreased content of S1P has been found to be also associated with neurodegeneration in Alzheimer’s disease (AD)25–27. The gene discussed is SGPL1; the disease is Alzheimer disease.